Researchers find epigenetic switch that helps keep early embryo cells on the right track
An international team of researchers identifies how a protein complex called Polycomb controls the very first cell fate decision towards either placenta or foetus during human embryonic development.
Limiting inflammation may improve ‘flu vaccination response in older people
By analysing immune responses across people of different ages after seasonal influenza vaccination, immunologists at the Babraham Institute have shown that a particular type of white blood cell, circulating T follicular helper cells, is linked with good influenza antibody responses in younger people. But that in people over 65, the formation of these cells upon vaccination is reduced compared to…
Vaccines explained for children in book – 'Maya’s Marvellous Medicine'
Professor Adrian Liston, Senior Group Leader at the Babraham Institute, and artist Dr Sonia Agüera-Gonzalez have published a captivating story book to teach children about the immune system and why vaccinations are important.
The Babraham Research Campus receives funding for barrier-busting PhD programme
Babraham Research Campus Ltd, which develops and manages the Babraham Research Campus, and the Babraham Institute have secured funding for 15 PhD studentships from UKRI-BBSRC as part of a Collaborative Training Partnership (CTP). Through a tailored programme of skills training and scientific and industry supervision, the partnership will produce a cohort of bioscience researchers equipped with…
Babraham Institute welcomes new group leaders
Dr Ian McGough is the first of four new group leaders to join the Babraham Institute in positions split across, and in some cases bridging, the Institute's Signalling and Epigenetics research programmes.
Institute welcomes future vision for the Babraham Research Campus
The Babraham Institute welcomes the Babraham Research Campus strategy to develop the Campus into “one of the best places in the world for discovery bioscience research and innovation.”
Professor Wolf Reik, FRS, FMedSci appointed Director of the Babraham Institute
Following an open and international search, Professor Wolf Reik has been appointed by the Babraham Institute Board of Trustee Directors as the Institute’s Director. Professor Reik has held the position of Acting Director since May 2020 following the tragic death of Professor Michael Wakelam.
New Trustees join Babraham Institute Board
The Babraham Institute has recently made four new appointments to the Institute’s Board of Trustees.
Enhanc3D Genomics appoints Dr Frank M Armstrong as Chair of the Board of Directors
Enhanc3D Genomics, a functional genomics spinout company from The Babraham Institute (Cambridge, UK), is pleased to announce that Dr Frank M Armstrong has been appointed as Chair of the Board of Directors of the Company with effect from 4 January 2021.
Professor Wolf Reik FRS appointed Acting Director of the Babraham Institute
Professor Wolf Reik has been appointed Acting Director of the Babraham Institute with immediate effect, following the sad loss of Professor Michael Wakelam at the end of March.
Children’s book ‘Battle Robots of the Blood’ now available
Immunology expertise has combined with beautifully evocative illustrations to create an engaging book for children and their parents. A new children’s book ‘Battle Robots of the Blood’ has been launched, available as an e-book for free during the coronavirus lockdown.
Michael Wakelam 1955 - 2020
The Babraham Institute is devastated to announce the news of the death of Professor Michael Wakelam, the Institute’s Director.
New group leader joins the Epigenetics research programme at the Babraham Institute
Dr Maria Christophorou joins the Institute as a group leader in the Epigenetics research programme.
EU grant success to harness the immune system to treat brain damage
Pioneering research by Professor Adrian Liston, a senior group leader at the Babraham Institute, will be developed towards being market-ready for the treatment of brain injury by funding provided by an ERC (European Research Council) Proof of Concept grant.
Michelle Linterman receives Lister Prize
Dr Michelle Linterman, a group leader in the Babraham Institute’s Immunology research programme, has received a prestigious Lister Institute Research Prize Fellowship.
Profiling immune system in paediatric arthritis patients offers hope for improved diagnosis
Researchers design a machine learning algorithm with ~90% accuracy in identifying children with arthritis using blood samples alone, creating a potential diagnostic tool to improve diagnosis and treatment.
Naïve, primed or somewhere in between?
Single cell analysis reveals details of heterogeneity in stem cell populations and how naive cells become primed for differentiation. Research also identified a new intermediate cell population showing characteristics of naïve and primed human embryonic stem cells which might be present in the early human embryo.
How lung tissue forms immune cell hubs in times of need
Immunology researchers at the Babraham Institute have uncovered how lung tissue is remodelled to support an immune response to influenza. If the research findings can be applied to the development of the seasonal influenza vaccination, the result would be more robust protection against multiple influenza strains. Findings are also relevant to understanding a variety of autoimmune diseases and the…
Kick-starting the genome in early development
We can think of the egg and sperm as information capsules with stored instructions for starting a new life, but post fertilisation, what kick starts the interpretation of these instructions?
Babraham Institute steps-up equality, diversity & inclusion commitments
The Institute is delighted to have joined both the Equality, Diversity and Inclusion in Science and Health (EDIS) coalition and the Stonewall Diversity Champions programme for embedding LGBT inclusion.
What can worms tell us about human ageing?
Community-developed blueprint of worm metabolism holds promise for greater understanding of ageing.
Wolf Reik awarded Wellcome Trust Investigator Award
Professor Wolf Reik, Associate Director and Head of the Epigenetics research programme at the Babraham Institute has been awarded a Wellcome Trust Investigator Award for research into how to reprogramme the epigenome. The Award provides £2.6 million in funding for five years. Research funded by the award will commence in October this year and involve the recruitment of three new research…
Placenta defects key factor in prenatal deaths
The role of the placenta in healthy fetal development is being seriously under-appreciated, according to a new paper published last week.
Genes for age-linked brain deterioration identified
A group of genes and genetic switches involved in age-related brain deterioration have been identified by scientists at the Babraham Institute, Cambridge and Sapienza University, Rome.
Reik Lab part of team shortlisted for Cancer Research UK’s Grand Challenge Award
A multi-disciplinary team of scientists, including Professor Wolf Reik from the Babraham Institute, has been shortlisted to the final stages of Cancer Research UK's Grand Challenge* – an ambitious series of £20m global grants tackling some of the toughest questions in cancer research.